Cargando…
HALT & REVERSE: Hsf1 activators lower cardiomyocyt damage; towards a novel approach to REVERSE atrial fibrillation
BACKGROUND: Atrial fibrillation is a progressive arrhythmia, the exact mechanism underlying the progressive nature of recurrent AF episodes is still unknown. Recently, it was found that key players of the protein quality control system of the cardiomyocyte, i.e. Heat Shock Proteins, protect against...
Autores principales: | Lanters, Eva A. H., van Marion, Denise M. S., Kik, Charles, Steen, Herman, Bogers, Ad J. J. C., Allessie, Maurits A., Brundel, Bianca J. J. M., de Groot, Natasja M. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635598/ https://www.ncbi.nlm.nih.gov/pubmed/26541406 http://dx.doi.org/10.1186/s12967-015-0714-7 |
Ejemplares similares
-
The Impact of Filter Settings on Morphology of Unipolar Fibrillation Potentials
por: Starreveld, Roeliene, et al.
Publicado: (2020) -
QUest for the Arrhythmogenic Substrate of Atrial fibRillation in Patients Undergoing Cardiac Surgery (QUASAR Study): Rationale and Design
por: van der Does, Lisette J. M. E., et al.
Publicado: (2016) -
Mitochondrial Dysfunction Underlies Cardiomyocyte Remodeling in Experimental and Clinical Atrial Fibrillation
por: Wiersma, Marit, et al.
Publicado: (2019) -
Cell-Free Circulating Mitochondrial DNA: A Potential Blood-Based Marker for Atrial Fibrillation
por: Wiersma, Marit, et al.
Publicado: (2020) -
Atrial fibrillation: A never ending story?
por: Lanters, Eva A. H., et al.
Publicado: (2019)